Company news from the 04/17/07 news brief

Share this article:
Blue Diesel, an inVentiv Health company focused exclusively on interactive marketing, recently opened an office in Newtown, PA. The new location was opened to provide expanded service to Blue Diesel's growing base of clients on the East Coast. “Expanding our operations is an exciting step for us," said Kelly Gratz, president of Blue Diesel. "This new location will allow us to work more collaboratively with our East Coast clients while still leveraging our Columbus-based office.” The new office will be located at 41 University Drive, in a building that is shared by several other inVentiv Health companies. Pharmaceutical industry daily digest FirstWord has launched a mobile edition identical to its PC version that is compatible with most handheld devices and poised to tap into subscribers currently served by BlackBerry. The new edition, called FirstWord Mobile, is believed to be the only mobile publication that allows subscribers to customize its content, selecting specific drugs, world markets and international companies to follow on a daily basis.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...